financetom
Business
financetom
/
Business
/
Arch Resources, Consol Energy Merger Clears Hart-Scott-Rodino Antitrust Waiting Period
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Arch Resources, Consol Energy Merger Clears Hart-Scott-Rodino Antitrust Waiting Period
Oct 17, 2024 2:34 PM

07:19 AM EDT, 10/14/2024 (MT Newswires) -- Arch Resources ( ARCH ) and Consol Energy (CEIX) said Monday that the waiting period under the Hart-Scott-Rodino antitrust act expired Friday, removing a regulatory hurdle in the pending merger of the two companies.

The business combination remains subject to other closing conditions, including approval by shareholders of both companies.

Price: 145.05, Change: -0.75, Percent Change: -0.51

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Steel Partners and Camac Partners Send Letter to TuSimple Proposing to Acquire Company for $0.46 per Share in Cash
BRIEF-Steel Partners and Camac Partners Send Letter to TuSimple Proposing to Acquire Company for $0.46 per Share in Cash
Dec 2, 2024
Dec 2 (Reuters) - Steel Partners Holdings LP ( SPLP ): * STEEL PARTNERS AND CAMAC PARTNERS SEND LETTER TO TUSIMPLE PROPOSING TO ACQUIRE COMPANY FOR $0.46 PER SHARE IN CASH Source text: Further company coverage: ...
BRIEF-Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B
BRIEF-Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B
Dec 2, 2024
Dec 2 (Reuters) - Hepion Pharmaceuticals Inc ( HEPA ): * HEPION PHARMACEUTICALS ISSUES LETTER TO SHAREHOLDERS URGING SUPPORT FOR PROPOSED MERGER WITH PHARMA TWO B Source text: Further company coverage: ...
Esperion Therapeutics Files Applications for Non-Statin Medications in Canada
Esperion Therapeutics Files Applications for Non-Statin Medications in Canada
Dec 2, 2024
08:30 AM EST, 12/02/2024 (MT Newswires) -- Esperion Therapeutics ( ESPR ) said Monday it has submitted New Drug Submissions to Health Canada for Nexletol and Nexlizet, oral non-statin medications designed to lower LDL cholesterol and potentially reduce cardiovascular risks in patients unable to tolerate statins. The company said the medications are intended for adults with established cardiovascular disease or...
BRIEF-Nut Tree Capital Management And Caspian Capital File Definitive Proxy Materials Opposing Merger Between Martin Midstream Partners And Martin Resource Management Corporation
BRIEF-Nut Tree Capital Management And Caspian Capital File Definitive Proxy Materials Opposing Merger Between Martin Midstream Partners And Martin Resource Management Corporation
Dec 2, 2024
Dec 2 (Reuters) - * NUT TREE CAPITAL MANAGEMENT AND CASPIAN CAPITAL FILE DEFINITIVE PROXY MATERIALS OPPOSING MERGER BETWEEN MARTIN MIDSTREAM PARTNERS AND MARTIN RESOURCE MANAGEMENT CORPORATION Source text: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved